Company attributes
Venture Capital Firm attributes
Other attributes
Signet Healthcare Partners is a venture capital company that aims to invest in commercial-stage companies in the healthcare industry. Founded 1998 in New York, United States, this venture capita; firm invests in early and late stage ventures. Its portfolio companies include Smart Medical Systems, Leading Pharma, TELA Bio, leon nanodrugs, Bion Pharma, KEW Group, Sancilio and Company, Fluxion Biosciences, Arbor Pharmaceuticals and Pfenex. As of February 2020, Signet Healthcare Partners has made 15 investments. Their most recent investment was on Feb 14, 2018, when Smart Medical Systems raised $8M. Signet Healthcare Partners has had 5 exits, the most notable of which include TELA Bio, Pfenex, and DIREVO Industrial Biotechnology. The company has raised two funds, their latest being Signet Healthcare Partners IV L.P.. This fund was announced on Jan 11, 2017 and raised a total of $137.2M.
The firm seeks to invest in firms operating in the healthcare, life science, specialty pharmaceutical, medical device, diagnostic and pharmaceutical service sectors.
